Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP09178407.4Aexternal-prioritypatent/EP2177536B1/en
Application filed by Glaxo Group LimitedfiledCriticalGlaxo Group Limited
Publication of CY1115559T1publicationCriticalpatent/CY1115559T1/en
Αντισώματα που συνδέονται με ανθρώπινο β-αμυλοειδές πεπτίδιο, μέθοδοι θεραπείας ασθενειών ή διαταραχών που χαρακτηρίζονται από αυξημένα επίπεδα β-αμυλοειδούς ή εναποθέσεις β-αμυλοειδούς με τα αναφερόμενα αντισώματα, φαρμακευτικές συνθέσεις που περιέχουν τα αναφερόμενα αντισώματα και μέθοδοι παρασκευής.Antibodies associated with human β-amyloid peptide, methods of treatment of diseases or disorders characterized by elevated levels of β-amyloid or beta-amyloid deposits with said antibodies, pharmaceutical compositions containing said antibodies and methods of preparation.